Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Universal Corp
UVV
$1.38B
| $3.3M | ﹤0.01% |
56,000
+600
| +1% | +$35.4K |
|
1702
PBF Energy
PBF
$3.18B
| $3.3M | ﹤0.01% |
233,300
+2,100
| +0.9% | +$29.7K |
|
|
POLY
1703
DELISTED
Plantronics, Inc.
POLY
| $3.3M | ﹤0.01% |
84,800
+2,000
| +2% | +$77.8K |
|
1704
ProAssurance
PRA
$1.22B
| $3.3M | ﹤0.01% |
123,200
+1,200
| +1% | +$32.1K |
|
1705
Independence Realty Trust
IRT
$4.07B
| $3.29M | ﹤0.01% |
216,700
+2,000
| +0.9% | +$30.4K |
|
1706
Cal-Maine
CALM
$5.37B
| $3.28M | ﹤0.01% |
85,400
+700
| +0.8% | +$26.9K |
|
|
SWTX
1707
DELISTED
SpringWorks Therapeutics
SWTX
| $3.28M | ﹤0.01% |
44,600
+1,400
| +3% | +$103K |
|
1708
Greif
GEF
$3.59B
| $3.27M | ﹤0.01% |
57,400
+900
| +2% | +$51.3K |
|
1709
Pitney Bowes
PBI
$1.96B
| $3.26M | ﹤0.01% |
395,600
+4,300
| +1% | +$35.4K |
|
1710
AMC Networks
AMCX
$357M
| $3.25M | ﹤0.01% |
61,200
+900
| +1% | +$47.8K |
|
1711
IAMGOLD
IAG
$6.42B
| $3.23M | ﹤0.01% |
1,085,900
+10,700
| +1% | +$31.8K |
|
1712
Tanger
SKT
$3.86B
| $3.23M | ﹤0.01% |
213,500
+1,700
| +0.8% | +$25.7K |
|
1713
Surgery Partners
SGRY
$2.8B
| $3.23M | ﹤0.01% |
72,900
+21,400
| +42% | +$947K |
|
|
LMNX
1714
DELISTED
Luminex Corp
LMNX
| $3.22M | ﹤0.01% |
101,000
+1,400
| +1% | +$44.7K |
|
1715
Dine Brands
DIN
$368M
| $3.21M | ﹤0.01% |
35,700
+300
| +0.8% | +$27K |
|
|
VRE
1716
Veris Residential
VRE
$1.49B
| $3.21M | ﹤0.01% |
207,200
+1,900
| +0.9% | +$29.4K |
|
1717
Tennant Co
TNC
$1.5B
| $3.2M | ﹤0.01% |
40,100
+400
| +1% | +$32K |
|
1718
Camping World
CWH
$1.04B
| $3.2M | ﹤0.01% |
88,000
+1,300
| +1% | +$47.3K |
|
1719
Pathward Financial
CASH
$1.72B
| $3.2M | ﹤0.01% |
70,600
| – | – |
|
1720
Heron Therapeutics
HRTX
$193M
| $3.2M | ﹤0.01% |
197,200
+2,000
| +1% | +$32.4K |
|
1721
Aurinia Pharmaceuticals
AUPH
$1.68B
| $3.2M | ﹤0.01% |
245,900
+1,900
| +0.8% | +$24.7K |
|
1722
AAR Corp
AIR
$2.67B
| $3.2M | ﹤0.01% |
76,700
+1,100
| +1% | +$45.8K |
|
1723
James River Group
JRVR
$244M
| $3.19M | ﹤0.01% |
69,999
+800
| +1% | +$36.5K |
|
1724
Stewart Information Services
STC
$2.09B
| $3.18M | ﹤0.01% |
61,100
+700
| +1% | +$36.4K |
|
1725
Beam Therapeutics
BEAM
$2.08B
| $3.18M | ﹤0.01% |
39,700
+1,400
| +4% | +$112K |
|